HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hidehito Horinouchi Selected Research

Small Cell Lung Carcinoma (Small Cell Lung Cancer)

1/2021Differential Efficacy of Pembrolizumab According to Metastatic Sites in Patients With PD-L1 Strongly Positive (TPS ≥ 50%) NSCLC.
5/2020History of Japan Clinical Oncology Group (JCOG) Lung Cancer Study Group.
1/2018Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions.
1/2017Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.
9/2014Adjuvant chemotherapy in patients with completely resected small cell lung cancer: a retrospective analysis of 26 consecutive cases.
9/2009[Two cases of invasive pulmonary aspergillosis mimicking pneumonia in lung cancer patients].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hidehito Horinouchi Research Topics

Disease

71Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 08/2008
43Neoplasms (Cancer)
11/2022 - 08/2011
13Lung Neoplasms (Lung Cancer)
04/2022 - 07/2011
10Disease Progression
05/2022 - 01/2015
7Neutropenia
10/2020 - 08/2008
7Thymoma (Thymic Carcinoma)
10/2020 - 08/2011
6Interstitial Lung Diseases (Interstitial Lung Disease)
07/2022 - 04/2013
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 09/2009
5Carcinoma (Carcinomatosis)
01/2022 - 07/2011
5Adenocarcinoma of Lung
11/2021 - 04/2012
5Neoplasm Metastasis (Metastasis)
01/2020 - 04/2013
4Leukopenia
01/2020 - 07/2014
3Pneumonia (Pneumonitis)
10/2022 - 09/2009
3Thrombocytopenia (Thrombopenia)
01/2020 - 07/2014
2Stomach Neoplasms (Stomach Cancer)
01/2022 - 12/2016
2Exanthema (Rash)
10/2020 - 01/2017
2Adrenal Insufficiency (Adrenal Gland Hypofunction)
03/2020 - 01/2019
2Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 02/2014
2Anemia
01/2020 - 11/2015
2Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 12/2016
2Brain Neoplasms (Brain Tumor)
04/2013 - 04/2012
1Overweight
03/2022
1Cachexia
02/2022
1Adenocarcinoma
01/2022
1Lymphoma (Lymphomas)
01/2022
1Fatigue
10/2020
1Pleurisy (Pleuritis)
05/2020
1Pericarditis
05/2020
1Febrile Neutropenia
01/2020
1Malignant Mesothelioma
11/2019

Drug/Important Bio-Agent (IBA)

16ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2012
13Tyrosine Kinase InhibitorsIBA
07/2019 - 01/2012
12NivolumabIBA
01/2022 - 10/2018
10pembrolizumabIBA
10/2022 - 12/2020
10Cisplatin (Platino)FDA LinkGeneric
04/2022 - 02/2012
10B7-H1 AntigenIBA
03/2022 - 05/2015
9Immune Checkpoint InhibitorsIBA
03/2022 - 03/2016
8Pharmaceutical PreparationsIBA
07/2022 - 01/2012
7PlatinumIBA
01/2022 - 04/2012
7LigandsIBA
01/2022 - 05/2015
7Biomarkers (Surrogate Marker)IBA
11/2021 - 06/2015
7Carboplatin (JM8)FDA LinkGeneric
01/2020 - 08/2011
6Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2022 - 04/2013
5Gefitinib (Iressa)FDA Link
07/2021 - 04/2013
5Monoclonal AntibodiesIBA
11/2019 - 06/2015
5Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 08/2011
4Pemetrexed (MTA)FDA Link
08/2021 - 04/2013
4Alanine Transaminase (SGPT)IBA
10/2020 - 11/2015
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2020 - 07/2014
4Docetaxel (Taxotere)FDA Link
01/2020 - 10/2018
3alectinibIBA
05/2022 - 01/2017
3nintedanibIBA
03/2022 - 01/2018
3SolutionsIBA
12/2021 - 01/2018
3CrizotinibIBA
03/2020 - 08/2016
3amrubicinIBA
11/2019 - 07/2011
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2019 - 11/2015
3Vinorelbine (Navelbine)FDA LinkGeneric
08/2013 - 02/2012
2Antineoplastic Agents (Antineoplastics)IBA
07/2022 - 07/2022
2durvalumabIBA
04/2022 - 01/2022
2AntiemeticsIBA
04/2022 - 05/2020
2EnzymesIBA
04/2022 - 10/2018
2IpilimumabIBA
01/2022 - 08/2015
2RamucirumabIBA
01/2022 - 01/2019
2Programmed Cell Death 1 ReceptorIBA
01/2021 - 10/2018
2osimertinibIBA
01/2019 - 07/2017
2Phosphotransferases (Kinase)IBA
01/2019 - 07/2014
2Anaplastic Lymphoma KinaseIBA
09/2018 - 01/2017
2ceritinibIBA
09/2018 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 02/2016
2patritumabIBA
12/2016 - 06/2015
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2016 - 07/2014
2linifanibIBA
02/2016 - 07/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2022
1Aprepitant (Emend)FDA Link
04/2022
1Cytochrome P-450 CYP3AIBA
04/2022
1LeptinIBA
02/2022
1Interleukin-1alpha (Interleukin 1 alpha)IBA
02/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2022
1Interleukin-8 (Interleukin 8)IBA
02/2022
1Hormones (Hormone)IBA
02/2022
1Interleukin-10 (Interleukin 10)IBA
02/2022
1CytokinesIBA
02/2022
1MetalloproteinsIBA
11/2021
1MicroRNAs (MicroRNA)IBA
11/2021
1Transforming Growth Factor beta (TGF-beta)IBA
11/2021
1Death Domain ReceptorsIBA
01/2021
1AfatinibIBA
11/2020
1Glycoproteins (Glycoprotein)IBA
11/2019
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
11/2019

Therapy/Procedure

31Drug Therapy (Chemotherapy)
11/2022 - 09/2009
29Therapeutics
07/2022 - 08/2008
12Chemoradiotherapy
04/2022 - 01/2012
9Radiotherapy
11/2021 - 01/2012
4Combination Drug Therapy (Combination Chemotherapy)
01/2022 - 08/2008
2Neoadjuvant Therapy
01/2022 - 01/2020
2Molecular Targeted Therapy
01/2022 - 12/2015
2Immunotherapy
11/2021 - 05/2015
1Gastrectomy
01/2022
1Lasers (Laser)
01/2022
1Drug Tapering
01/2020